Literature DB >> 21366419

Expression and secretion hierarchy in the nonflagellar type III secretion system.

Suzanne E Osborne1, Brian K Coombes.   

Abstract

Type III secretion systems that deliver bacterial proteins into eukaryotic cells are the basis for both symbiotic and pathogenic relationships between many Gram-negative bacteria and their hosts. Exploration of the structure, function and assembly of this secretion system has greatly enhanced our knowledge of bacterial ecology in the context of infectious disease and has spawned new avenues in anti-infective research with a view towards inhibiting virulence functions. We outline advances in understanding type III secretion system function with specific focus on how assembly is hierarchically coordinated at the level of expression and how the type III secretion system mediates transitions in substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366419     DOI: 10.2217/fmb.10.172

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  10 in total

Review 1.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis.

Authors:  Michelle D Glew; Paul D Veith; Benjamin Peng; Yu-Yen Chen; Dhana G Gorasia; Qiaohui Yang; Nada Slakeski; Dina Chen; Caroline Moore; Simon Crawford; Eric C Reynolds
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

Review 3.  Active modification of host inflammation by Salmonella.

Authors:  Ana Victoria C Pilar; Sarah A Reid-Yu; Colin A Cooper; David T Mulder; Brian K Coombes
Journal:  Gut Microbes       Date:  2013-01-18

4.  Role of EscP (Orf16) in injectisome biogenesis and regulation of type III protein secretion in enteropathogenic Escherichia coli.

Authors:  Julia Monjarás Feria; Elizabeth García-Gómez; Norma Espinosa; Tohru Minamino; Keiichi Namba; Bertha González-Pedrajo
Journal:  J Bacteriol       Date:  2012-08-24       Impact factor: 3.490

5.  Edwardsiella tarda EscE (Orf13 Protein) Is a Type III Secretion System-Secreted Protein That Is Required for the Injection of Effectors, Secretion of Translocators, and Pathogenesis in Fish.

Authors:  Jin Fang Lu; Wei Na Wang; Gai Ling Wang; He Zhang; Ying Zhou; Zhi Peng Gao; Pin Nie; Hai Xia Xie
Journal:  Infect Immun       Date:  2015-10-12       Impact factor: 3.441

6.  A Fresh Look at the Type III Secretion System: Two-Step Model of Effector Translocation in Pathogenic Bacteria.

Authors:  Ana Victoria C Pilar; Brian K Coombes
Journal:  Front Microbiol       Date:  2011-05-18       Impact factor: 5.640

7.  LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis.

Authors:  Keke Fei; Huan Yan; Xiaoyan Zeng; Shaojia Huang; Wei Tang; Matthew S Francis; Shiyun Chen; Yangbo Hu
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

8.  Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.

Authors:  Ayad A A Amer; Tiago R D Costa; Salah I Farag; Ummehan Avican; Åke Forsberg; Matthew S Francis
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

9.  Heterologous Complementation Studies With the YscX and YscY Protein Families Reveals a Specificity for Yersinia pseudotuberculosis Type III Secretion.

Authors:  Jyoti M Gurung; Ayad A A Amer; Monika K Francis; Tiago R D Costa; Shiyun Chen; Anton V Zavialov; Matthew S Francis
Journal:  Front Cell Infect Microbiol       Date:  2018-03-16       Impact factor: 5.293

10.  Type III secretion by Yersinia pseudotuberculosis is reliant upon an authentic N-terminal YscX secretor domain.

Authors:  Jyoti M Gurung; Ayad A A Amer; Shiyun Chen; Andreas Diepold; Matthew S Francis
Journal:  Mol Microbiol       Date:  2022-02-08       Impact factor: 3.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.